<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4964">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01989702</url>
  </required_header>
  <id_info>
    <org_study_id>ProMeta</org_study_id>
    <nct_id>NCT01989702</nct_id>
  </id_info>
  <brief_title>Effect of a Probiotic-based Product on Blood Pressure</brief_title>
  <official_title>The Effect of a Probiotic-based Product on Blood Pressure and Other Known Risk Factors Linked to Cardiovascular Diseases.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Probi AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Probi AB</source>
  <oversight_info>
    <authority>Sweden: Ethical review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study was to examine the efficacy of a probiotic-based product on
      either reducing hypertension or preventing a high normal blood pressure from reaching
      hypertensive levels.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Changes from baseline in systolic and diastolic blood pressure after 3 months of probiotic intervention</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline of blood parameters, such as inflammatory markers and blood lipids, linked to increased risk for cardiovascular diseases</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Effect of study product on intestinal microbiota as analysed in fecal samples</measure>
    <time_frame>Baseline, 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">142</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Fermented blueberry product</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic bacteria</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fermented blueberry drink</intervention_name>
    <arm_group_label>Fermented blueberry product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo drink</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Probiotic bacteria</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sachets with probiotic bacterial powder</intervention_name>
    <arm_group_label>Probiotic bacteria</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sachets with placebo powder</intervention_name>
    <arm_group_label>Fermented blueberry product</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy individuals at the age of 40-75 years.

          -  Blood-pressure &gt;140/90 mmHg that has been confirmed at 2-3 separate occasions or
             represents the mean value of a 24-hour measurement.

          -  Triglycerides &gt;1,7 mmol/L and/or HDL &lt;1 mmol/L (men)/1,29 mmol/L (women).

          -  Fasting plasma glucose levels &gt;5,6 mmol/L and/or waist circumference &gt;102 cm (men)/88
             cm (women).

          -  BMI &lt;40.

        Exclusion Criteria:

          -  Medically treated allergy or allergy to any of the ingredients of the study product.

          -  Medication for high levels of blood lipids.

          -  Metabolic disease, such as type one diabetes.

          -  Confirmed diseases of the heart, liver of kidneys.

          -  Chronic inflammatory disease requiring medication.

          -  Pregnant or nursing.

          -  Regular intake of other probiotic products (5-7 days per week during the last three
             months before inclusion into the study).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Malm√∂</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 14, 2013</lastchanged_date>
  <firstreceived_date>November 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
